Tumor Response and Survival Predicted by Post-Therapy FDG-PET/CT in Anal Cancer

International Journal of Radiation Oncology Biology Physics

Volumn 71, Issue 1, 2008, Pages 180-186

  Schwarz, Julie K ^a   Siegel, Barry A ^b,c   Dehdashti, Farrokh ^b,c   Myerson, Robert J ^a,c   Fleshman, James W ^a,c   Grigsby, Perry W ^a,b,c  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c USA   (United States)

Author keywords

Anal cancer; Chemoradiotherapy; FDG PET CT; Response

Indexed keywords

CHEMOTHERAPY; COMPUTERIZED TOMOGRAPHY; MEDICAL IMAGING; POSITRON EMISSION TOMOGRAPHY; RADIOTHERAPY;

ANAL CANCER; CHEMORADIOTHERAPY; SURVIVAL RATE; TUMOR RESPONSE;

TUMORS;

FLUORODEOXYGLUCOSE F 18; FLUOROURACIL; MITOMYCIN C;

ADULT; AGED; ANUS CANCER; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIAGNOSTIC IMAGING; EXTERNAL BEAM RADIOTHERAPY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RECTUM BIOPSY; SURVIVAL RATE; TREATMENT RESPONSE;

ADULT; AGED; AGED, 80 AND OVER; ANUS NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 41849086677     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2007.09.005     Document Type: Article

References (29)

1. Johnson L.G., Madeleine M.M., Newcomer L.M., et al. Anal cancer incidence and survival: The Surveillance, Epidemiology, and End Results experience, 1973-2000. Cancer 101 (2004) 281-288
2. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J Clin 57 (2007) 43-66
3. Cotter S.E., Grigsby P.W., Siegel B.A., et al. FDG-PET/CT in the evaluation of anal carcinoma. Int J Radiat Oncol Biol Phys 65 (2006) 720-725
4. Engstrom PF, Arnoletti JP, Benson AB, et al. Available from: http://www.nccn.org/professionals/physician_gls/PDF/anal.pdf. Accessed October 18, 2007.
5. UK Coordinating Committee on Cancer Research (UKCCCR) Anal Cancer Trial Working Party. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. Lancet 348 (1996) 1049-1054
6. Bartelink H., Roelofsen F., Eschwege F., et al. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups. J Clin Oncol 15 (1997) 2040-2049
7. Flam M., John M., Pajak T.F., et al. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study. J Clin Oncol 14 (1996) 2527-2539
8. Touboul E., Schlienger M., Buffat L., et al. Epidermoid carcinoma of the anal canal: Results of curative-intent radiation therapy in a series of 270 patients. Cancer 73 (1994) 1569-1579
9. Myerson R.J., Kong F., Birnbaum E.H., et al. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61 (2001) 15-22
10. Chapet O., Gerard J.P., Riche B., et al. Prognostic value of tumor regression evaluated after first course of radiotherapy for anal canal cancer. Int J Radiat Oncol Biol Phys 63 (2005) 1316-1324
11. Tanum G., Tveit K.M., and Karlsen K.O. Chemoradiotherapy of anal carcinoma: Tumour response and acute toxicity. Oncology 50 (1993) 14-17
12. Borzomati D., Valeri S., Ripetti V., et al. Persisting perianal ulcer after radiotherapy for anal cancer: Recurrence of disease or late radiation-related complication?. Hepatogastroenterology 52 (2005) 780-784
13. MacManus M.P., Hicks R.J., Matthews J.P., et al. Positron emission tomography is superior to computed tomography scanning for response-assessment after radical radiotherapy or chemoradiotherapy in patients with non-small-cell lung cancer. J Clin Oncol 21 (2003) 1285-1292
14. MacManus M.P., Hicks R.J., Matthews J.P., et al. Metabolic (FDG-PET) response after radical radiotherapy/chemoradiotherapy for non-small cell lung cancer correlates with patterns of failure. Lung Cancer 49 (2005) 95-108
15. Cheson B.D., Pfistner B., Juweid M.E., et al. Revised response criteria for malignant lymphoma. J Clin Oncol 25 (2007) 579-586
16. Juweid M.E., Stroobants S., Hoekstra O.S., et al. Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25 (2007) 571-578
17. Grigsby P.W., Siegel B.A., Dehdashti F., et al. Posttherapy surveillance monitoring of cervical cancer by FDG-PET. Int J Radiat Oncol Biol Phys 55 (2003) 907-913
18. 18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: Response and outcome. J Clin Oncol 22 (2004) 2167-2171
19. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 53 (1958) 457-481
20. Breslow N. A generalized Kruskall-Wallis test for comparing K samples subject to unequal patterns of censorship. Biometrika 57 (1970) 579-594
21. Schwarz J.K., Siegel B.A., Dehdashti F., et al. Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma. JAMA 298 (2007) 2289-2295
22. Deniaud-Alexandre E., Touboul E., Tiret E., et al. Results of definitive irradiation in a series of 305 epidermoid carcinomas of the anal canal. Int J Radiat Oncol Biol Phys 56 (2003) 1259-1273
23. Allal A.S., Laurencet F.M., Reymond M.A., et al. Effectiveness of surgical salvage therapy for patients with locally uncontrolled anal carcinoma after sphincter-conserving treatment. Cancer 86 (1999) 405-409
24. Nilsson P.J., Svensson C., Goldman S., et al. Salvage abdominoperineal resection in anal epidermoid cancer. Br J Surg 89 (2002) 1425-1429
25. Akbari R.P., Paty P.B., Guillem J.G., et al. Oncologic outcomes of salvage surgery for epidermoid carcinoma of the anus initially managed with combined modality therapy. Dis Colon Rectum 47 (2004) 1136-1144
26. Mullen J.T., Rodriguez-Bigas M.A., Chang G.J., et al. Results of surgical salvage after failed chemoradiation therapy for epidermoid carcinoma of the anal canal. Ann Surg Oncol 14 (2007) 478-483
27. Ellenhorn J.D., Enker W.E., and Quan S.H. Salvage abdominoperineal resection following combined chemotherapy and radiotherapy for epidermoid carcinoma of the anus. Ann Surg Oncol 1 (1994) 105-110
28. Pocard M., Tiret E., Nugent K., et al. Results of salvage abdominoperineal resection for anal cancer after radiotherapy. Dis Colon Rectum 41 (1998) 1488-1493
29. van der Wal B.C., Cleffken B.I., Gulec B., et al. Results of salvage abdominoperineal resection for recurrent anal carcinoma following combined chemoradiation therapy. J Gastrointest Surg 5 (2001) 383-387